363 related articles for article (PubMed ID: 21342042)
1. Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.
Smith DG; Magwere T; Burchill SA
Expert Rev Anticancer Ther; 2011 Feb; 11(2):229-49. PubMed ID: 21342042
[TBL] [Abstract][Full Text] [Related]
2. Manipulation of oxidative stress to induce cell death in Ewing's sarcoma family of tumours.
Magwere T; Myatt SS; Burchill SA
Eur J Cancer; 2008 Oct; 44(15):2276-87. PubMed ID: 18656345
[TBL] [Abstract][Full Text] [Related]
3. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
Fang J; Seki T; Maeda H
Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
[TBL] [Abstract][Full Text] [Related]
5. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
6. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB activation prevents apoptotic oxidative stress via an increase of both thioredoxin and MnSOD levels in TNFalpha-treated Ewing sarcoma cells.
Djavaheri-Mergny M; Javelaud D; Wietzerbin J; Besançon F
FEBS Lett; 2004 Dec; 578(1-2):111-5. PubMed ID: 15581626
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
Myatt SS; Burchill SA
Oncogene; 2008 Feb; 27(7):985-96. PubMed ID: 17700534
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy and stem cell rescue for high-risk Ewing's family of tumors.
Rosenthal J; Pawlowska AB
Expert Rev Anticancer Ther; 2011 Feb; 11(2):251-62. PubMed ID: 21342043
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
Babizhayev MA
Cell Biochem Funct; 2011 Apr; 29(3):183-206. PubMed ID: 21381059
[TBL] [Abstract][Full Text] [Related]
12. Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species.
Hadi SM; Ullah MF; Shamim U; Bhatt SH; Azmi AS
Chemotherapy; 2010; 56(4):280-4. PubMed ID: 20714144
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic.
Lau AT; Wang Y; Chiu JF
J Cell Biochem; 2008 May; 104(2):657-67. PubMed ID: 18172854
[TBL] [Abstract][Full Text] [Related]
14. [Oxidative stress in cells damage processes].
Kulbacka J; Saczko J; Chwiłkowska A
Pol Merkur Lekarski; 2009 Jul; 27(157):44-7. PubMed ID: 19650429
[TBL] [Abstract][Full Text] [Related]
15. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
16. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
17. How to treat the Ewing's family of sarcomas in adult patients.
Scurr M; Judson I
Oncologist; 2006 Jan; 11(1):65-72. PubMed ID: 16401715
[TBL] [Abstract][Full Text] [Related]
18. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
19. Salvage chemotherapy for recurrent Ewing's sarcomas.
Ozaki T; Sugihara S; Hamada M; Nakagawa Y; Inoue H
Neoplasma; 1995; 42(1):39-42. PubMed ID: 7617074
[TBL] [Abstract][Full Text] [Related]
20. A matter of balance between life and death: targeting reactive oxygen species (ROS)-induced autophagy for cancer therapy.
Gibson SB
Autophagy; 2010 Oct; 6(7):835-7. PubMed ID: 20818163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
